The synthetic biology company has opened a new foundry to churn out mammal cells, first for drug development, and later to build potentially anything at all.
Ginkgo Bioworks Is Turning Human Cells Into On-Demand Factories
The synthetic biology company has opened a new foundry to churn out mammal cells, first for drug development, and later to build potentially anything at all.
